We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFX.L Regulatory News (AFX)

  • There is currently no data for AFX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Growth Share Schemes and PDMR Dealing

22 Jun 2022 07:00

RNS Number : 7629P
Alpha FX Group PLC
22 June 2022
 

22 June 2022

Alpha FX Group plc

("Alpha FX" or the "Company")

Growth Share Schemes and PDMR Dealing

Alpha FX Group plc (AIM: AFX), a high-tech, high-touch provider of FX risk management, accounts and payments solutions to corporates and institutions internationally, today wishes to provide an update with regard to changes to the Group's Employee Share Schemes.

 

Following on from the issuance of the E Share Growth Scheme in 2020, in which a total of 882 E Shares were issued to employees of the Group, the Group will be adopting three new Growth Share Schemes as described below resulting in a total of 910 shares being issued to employees of the Group.

 

F Share Growth Scheme

 

The Group will be adopting a growth share scheme, in addition to and on similar terms to the existing C Share Growth Scheme and E Share Growth Scheme under which 285 F ordinary shares ("F Shares") in Alpha FX Limited will be issued to certain employees of the Group ("F Share Growth Scheme").

 

The F Shares contain a put option, such that, when and to the extent vested, they can be converted into ordinary shares in Alpha FX Group plc ("Alpha"). The F Shares will vest in four equal tranches, occurring annually, in respect of the Financial Years for 2023, 2024, 2025 and 2026. Vesting for each Financial Year will require Group revenue growth of 20% in Financial Year 2023, 20% in Financial Year 2024, 20% in Financial Year 2025 and 20% in Financial Year 2026. The rate of conversion that the F Shares will be regarded as worth, is a pro rata share of the market capitalisation gain of Alpha above a hurdle price of £740 million. The gain that an F shareholder could receive is capped through placing a ceiling on the maximum market capitalisation of Alpha of £1,867 million. The result of doing so is that the F Shares will be entitled to a pro rata share of the gain in market capitalisation of Alpha between £740 million and the market capitalisation ceiling of £1,867 million.

 

Upon conversion, the number of ordinary shares in Alpha that an F Shareholder will receive is such number of ordinary shares whose value is equivalent to Alpha's closing share price at the conversion date. Conversion is only permitted to the extent that the F Shares have vested.

 

G Share Growth Scheme

 

The Group will be adopting a new growth share scheme under which 360 G ordinary shares ("G Shares") in Alpha FX Limited will be issued to certain employees ("G Shareholders") of the Group ("G Share Growth Scheme").

 

The G Shares contain a put option, such that, when and to the extent vested, they can be converted into ordinary shares in Alpha FX Group plc. The G Shares will vest in five tranches, occurring annually, in respect of the Financial Years for 2022, 2023, 2024, 2025 and 2026. The G Shareholders will be able to vest 12.5% of their holding for Financial Year 2022, 12.5% for Financial Year 2023, 25% for Financial Year 2024, 25% for Financial Year 2025 and 25% for Financial Year 2026. Vesting for each Financial Year will require revenue from the London Corporate division (and any future corporate division in Spain) to grow by 5.5% in Financial Year 2022, 15% in Financial Year 2023, 15% in Financial Year 2024, 15% in Financial Year 2025 and 15% in Financial Year 2026. The rate of conversion that the G Shares will be regarded as worth, is a pro rata share of the market capitalisation gain of Alpha above a hurdle price of £740 million. The gain that a G shareholder could receive is capped through placing a ceiling on the maximum market capitalisation of Alpha of £1,867 million. The result of doing so is that the G Shares will be entitled to a pro rata share of the gain in market capitalisation of Alpha between £740 million and the market capitalisation ceiling of £1,867 million.

 

Upon conversion, the number of ordinary shares in Alpha that a G Shareholder will receive is such number of ordinary shares whose value is equivalent to Alpha's closing share price at the conversion date. Conversion is only permitted to the extent that the G Shares have vested.

 

 

H Share Growth Scheme

 

The Group will be adopting a new growth share scheme under which 265 H ordinary shares ("H Shares") in Alpha FX Limited will be issued to certain employees ("H Shareholders") of the Group ("H Share Growth Scheme").

 

The H Shares contain a put option, such that, when and to the extent vested, they can be converted into ordinary shares in Alpha FX Group plc. The H Shares will vest in five tranches, occurring annually, in respect of the Financial Years for 2022, 2023, 2024, 2025 and 2026. The H Shareholders will be able to vest 12.5% of their holding for Financial Year 2022, 12.5% for Financial Year 2023, 25% for Financial Year 2024, 25% for Financial Year 2025 and 25% for Financial Year 2026. Vesting for each Financial Year is subject to 2 revenue targets being met, with H Shareholders being entitled to vest 50% of their holding for each Financial Year in respect of each target being met. The first revenue target is for the London Corporate division (and any future corporate division in Spain) to grow by 5.5% in Financial Year 2022, 15% in Financial Year 2023, 15% in Financial Year 2024, 15% in Financial Year 2025 and 15% in Financial Year 2026. The second target is for the revenue from all the global corporate divisions to grow by 18.6% in Financial Year 2022, 20% in Financial Year 2023, 20% in Financial Year 2024, 20% in Financial Year 2025 and 20% in Financial Year 2026. The rate of conversion that the H Shares will be regarded as worth, is a pro rata share of the market capitalisation gain of Alpha above a hurdle price of £740 million. The gain that an H shareholder could receive is capped through placing a ceiling on the maximum market capitalisation of Alpha of £1,867 million. The result of doing so is that the H Shares will be entitled to a pro rata share of the gain in market capitalisation of Alpha between £740 million and the market capitalisation ceiling of £1,867 million.

 

Upon conversion, the number of ordinary shares in Alpha an H Shareholder will receive is such number of ordinary shares whose value is equivalent to Alpha's closing share price at the conversion date. Conversion is only permitted to the extent that the H Shares have vested.

 

111 of the H Shares are being issued to Alex Howorth, who is a PDMR of the Company, and therefore the relevant regulatory disclosure has been made in the table below.

 

Enquiries:

 

Alpha FX Group plc

 

 

via Alma PR

Morgan Tillbrook, Founder and CEO

Tim Kidd, CFO

Liberum Capital Limited (Nominated Adviser and Sole Broker) 

Tel: +44 (0) 20 3100 2000

Neil Patel

Cameron Duncan

Kane Collings

Alma PR (Financial Public Relations)

Tel: +44 (0) 20 3405 0205

Josh Royston

Andy Bryant

Kieran Breheny

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Alex Howorth

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group Managing Director - FX Risk Management

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Alpha FX Group plc

b)

 

LEI

 

 

213800RESM1FPUXY6K31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

H ordinary shares in Alpha FX Limited, which may be convertible into ordinary shares in Alpha FX Group plc

Identification code

ISIN: GB00BF1TM596

b)

 

Nature of the transaction

 

 

Issue of H Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

111 H Shares

 

d)

 

Aggregated information

N/A

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

22 June 2022

f)

 

Place of the transaction

 

 

Off market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHELLBLLQLZBBD
Date   Source Headline
19th Dec 20224:02 pmRNSName Change to Alpha Group International
16th Dec 20227:00 amRNSUpdate on Name Change
22nd Nov 20222:04 pmRNSHolding(s) in Company
22nd Nov 202211:00 amRNSResult of General Meeting
10th Nov 20224:53 pmRNSHolding(s) in Company
4th Nov 20227:00 amRNSNotice of GM
4th Nov 20227:00 amRNSF Share Award
26th Oct 20224:22 pmRNSHolding(s) in Company
25th Oct 20225:47 pmRNSHolding(s) in Company
21st Oct 20227:00 amRNSTrading Update
19th Oct 20224:30 pmRNSHolding(s) in Company
19th Oct 20227:00 amRNSAppointment of CFO
18th Oct 20225:41 pmRNSHolding(s) in Company
10th Oct 20227:00 amRNSLaunch of New Website
14th Sep 20228:17 amRNSDirector/PDMR Shareholding
12th Sep 20225:20 pmRNSDirector/PDMR Shareholding
5th Sep 20227:00 amRNSInterim Report
21st Jul 20227:00 amRNSTrading Update
30th Jun 20227:00 amRNSTotal Voting Rights
22nd Jun 20227:00 amRNSGrowth Share Schemes and PDMR Dealing
6th Jun 20224:18 pmRNSHolding(s) in Company
31st May 20227:00 amRNSTotal Voting Rights
27th May 20224:25 pmRNSHolding(s) in Company
20th May 20224:56 pmRNSHolding(s) in Company
9th May 20223:51 pmRNSDirector/PDMR Shareholding
5th May 202211:27 amRNSResult of AGM
3rd May 20227:00 amRNSTotal Voting Rights
20th Apr 20222:21 pmRNSDirector/PDMR Shareholding
12th Apr 20227:00 amRNSNotice of AGM & Posting of Annual Report
6th Apr 20225:53 pmRNSHolding(s) in Company
6th Apr 20227:00 amRNSPDMR Shareholding
5th Apr 20227:00 amRNSTrading with Key Norwegian Client Recommences
31st Mar 20227:00 amRNSTotal Voting Rights
22nd Mar 20222:24 pmRNSHolding(s) in Company
22nd Mar 20227:00 amRNSBlock Admission Application
16th Mar 20224:13 pmRNSDirector/PDMR Shareholdings
16th Mar 20224:07 pmRNSIssue of Shares, Director/PDMR Shareholdings, TVR
16th Mar 20222:06 pmRNSSecond Price Monitoring Extn
16th Mar 20222:00 pmRNSPrice Monitoring Extension
16th Mar 20229:05 amRNSSecond Price Monitoring Extn
16th Mar 20229:00 amRNSPrice Monitoring Extension
16th Mar 20227:00 amRNSFull Year Results
14th Feb 20221:52 pmRNSHolding(s) in Company
10th Feb 20224:41 pmRNSSecond Price Monitoring Extn
10th Feb 20224:35 pmRNSPrice Monitoring Extension
10th Feb 20222:05 pmRNSSecond Price Monitoring Extn
10th Feb 20222:00 pmRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSTrading Update and Intended Board Change
13th Jan 20227:00 amRNSAppointment of MD for new Luxembourg office
23rd Dec 20217:00 amRNSRevision to APS Employee Share Ownership Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.